In yesterday’s Wall Street session, Sotera Health Company (NASDAQ:SHC) shares traded at $8.33, up 0.73% from the previous session.
8 analysts cover Sotera Health Company (NASDAQ:SHC), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $8.00 and a low of $6.00, we find $7.00. Given the previous closing price of $8.27, this indicates a potential downside of -15.36 percent. SHC stock price is now 10.47% away from the 50-day moving average and -45.94% away from the 200-day moving average. The market capitalization of the company currently stands at $2.33B.
The stock has received a hold rating from 5 analysts and a buy rating from 1. Brokers who have rated the stock have averaged $7.00 as their price target over the next twelve months.
With the price target maintained at $6, Barclays recently Downgraded its rating from Equal Weight to Underweight for Sotera Health Company (NASDAQ: SHC). On October 05, 2022, Citigroup Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $25 to quote $9, while ‘KeyBanc Capital Markets’ rates the stock as ‘Sector Weight’.
Insiders disposed of 31,162 shares of company stock worth roughly $0.26 million over the past 1 year. A total of 0.40% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in SHC stock. A new stake in Sotera Health Company shares was purchased by MIG CAPITAL, LLC during the first quarter worth $15,877,000. QUBE RESEARCH & TECHNOLOGIES LTD invested $12,608,000 in shares of SHC during the first quarter. In the first quarter, TWO SIGMA INVESTMENTS, LP acquired a new stake in Sotera Health Company valued at approximately $9,065,000. MARSHALL WACE, LLP acquired a new stake in SHC for approximately $7,042,000. STONEHILL CAPITAL MANAGEMENT LLC purchased a new stake in SHC valued at around $5,825,000 in the second quarter. In total, there are 256 active investors with 88.20% ownership of the company’s stock.
On Friday morning Sotera Health Company (NASDAQ: SHC) stock kicked off with the opening price of $8.15. During the past 12 months, Sotera Health Company has had a low of $5.78 and a high of $24.90. As of last week, the company has a debt-to-equity ratio of 2.97, a current ratio of 3.00, and a quick ratio of 2.70. The fifty day moving average price for SHC is $7.57 and a two-hundred day moving average price translates $15.35 for the stock.
The latest earnings results from Sotera Health Company (NASDAQ: SHC) was released for Jun, 2022. According to the Diagnostics & Research Company, earnings per share came in at $0.27, beating analysts’ expectations of $0.24 by 0.03. This compares to $0.10 EPS in the same period last year. The net profit margin was 11.60% and return on equity was 18.70% for SHC. The company reported revenue of $248.7 million for the quarter, compared to $226.16 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 9.97 percent. For the current quarter, analysts expect SHC to generate $248.2M in revenue.
Sotera Health Company(SHC) Company Profile
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company’s sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.